drugset / Trial / NCT01366339
Tolerance and Pharmacokinetics Study of MNTX Tablets
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-blind, randomized, placebo-controlled, phase I study in normal healthy volunteers. Study treatment includes single doses of MNTX and placebo. In addition, half of each active treatment group is further randomized to a second, replicate dose of MNTX, and the placebo group receives an additional placebo dose.
Timeline
- Start
- 2003-10
- Primary completion
- 2003-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylnaltrexone | Other / unclassified | — | Oral |
Indications
No indication recorded.